Search Results for citation:"86 FR 9520"

Found 2 results
Skip to main content

Search Results: citation:"86 FR 9520"

  • Type:Notice
    Citation:86 FR 9520
    Reading Time:about 2 minutes

    The National Institutes of Health (NIH) is announcing the availability of a government-owned invention for licensing. This invention involves monoclonal antibodies that can neutralize Epstein-Barr virus (EBV), which causes infectious mononucleosis and various cancers. These antibodies offer potential uses in diagnostics, therapeutics, and vaccine research. Interested parties can contact Peter Soukas for licensing opportunities or collaborative research to further develop and commercialize this technology.

    Simple Explanation

    The NIH has a special tool that can help fight a virus that makes people sick and can also lead to cancer. They are looking for people who want to work with them to test and use this tool to help others.

  • Type:Notice
    Citation:86 FR 9520
    Reading Time:about a minute or two

    The National Institute of Diabetes and Digestive and Kidney Diseases will hold a closed meeting on March 19, 2021, to review and evaluate grant applications. This meeting is closed to the public to protect confidential information and personal privacy, as it involves discussions on trade secrets and personal data. It will take place virtually at the National Institutes of Health in Bethesda, MD. Contact information for the Scientific Review Officer, Dr. Ryan G. Morris, is provided for any inquiries.

    Simple Explanation

    The National Institute of Diabetes and Digestive and Kidney Diseases is having a secret online meeting on March 19, 2021, to talk about special projects that need money, and only certain people can join to keep important information safe.